Inflammatory Breast Cancer (IBC)

Oncology·MeSH: Inflammatory Breast Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Inflammatory Breast Cancer (IBC)?

There are 1 clinical trial targeting Inflammatory Breast Cancer (IBC) tracked by BioSniper.

What is the prevalence of Inflammatory Breast Cancer (IBC)?

The estimated prevalence of Inflammatory Breast Cancer (IBC) is approximately 287.0 per 100,000 population.

Deep-dive into Inflammatory Breast Cancer (IBC)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Inflammatory Breast Cancer (IBC) — Drugs in Development & Clinical Trials | BioSniper